Targeting the circadian clock to restore hepatitis B T-cell immunity

针对生物钟恢复乙型肝炎 T 细胞免疫力

基本信息

  • 批准号:
    MR/X020843/1
  • 负责人:
  • 金额:
    $ 192.58万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Fellowship
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

Circadian rhythms regulate changes in physiological and metabolic processes which allow organisms on earth to respond to daily environmental demands and pathogenic exposure. Host innate and adaptive immune responses are circadian regulated and influence susceptibility to viral infection and response to vaccines. In recent years, scientists have discovered the genetic machinery that underpins the daily cycling of the circadian clock that operates in individual cells. Furthermore, scientists uncovered communications between circadian clocks of different cell types within an organ, and that genetically perturbing the clock in the hepatocytes can impact the clocks in their neighbouring immune cells. Therefore, there is reason to believe that the circadian clock controls immunity within the liver which is essential for viral protection. Hepatitis B virus (HBV) only infects the human liver and remains a major health problem with >270 million chronic infections and 880,000 deaths/year worldwide from liver disease including cirrhosis and cancer. Current antivirals reduce the viral burden but are not curative and do not remove the risk of liver cancer. Chronic hepatitis B is associated with poor anti-viral T-cell immunity that fails to control viral replication. Therefore, curative treatments are desperately needed, and understanding what causes these T-cell defects could aid the design and evaluation of curative therapies.We recently discovered a disruption of clock genes in the liver of HBV patients, which I hypothesise contributes to the poor T-cell response in the infected liver. Importantly, our recent data suggest that manipulation of circadian pathways by drugs can enhance the function of HBV-specific T-cells in CHB patients. Therefore by studying how the circadian system regulates T-cell immunity in the infected liver and how the time of day affects HBV vaccine efficacy, we will identify novel therapeutic opportunities for T-cell restoration and improve the efficacy of HBV therapeutic vaccines. In a broader context, knowledge of the communication of clocks between tissue and local immunity will be applicable to many other pathogens.
昼夜节律调节生理和代谢过程的变化,使地球上的生物体能够对日常环境需求和病原体暴露做出反应。宿主的先天性和适应性免疫应答受昼夜节律调节,并影响对病毒感染的易感性和对疫苗的应答。近年来,科学家们发现了支持个体细胞中生物钟日常循环的遗传机制。此外,科学家们发现了器官内不同细胞类型的生物钟之间的通信,并且遗传干扰肝细胞中的生物钟可以影响其邻近免疫细胞中的生物钟。因此,有理由相信生物钟控制肝脏内的免疫力,这对病毒保护至关重要。B型肝炎病毒(HBV)仅感染人类肝脏,并且仍然是一个主要的健康问题,全世界每年有> 2.7亿慢性感染和880,000人死于肝病,包括肝硬化和癌症。目前的抗病毒药物降低了病毒负荷,但不能治愈,也不能消除肝癌的风险。慢性B型肝炎与抗病毒T细胞免疫力低下有关,无法控制病毒复制。因此,迫切需要治愈性治疗,了解导致这些T细胞缺陷的原因可以帮助设计和评估治愈性疗法。我们最近发现HBV患者肝脏中的时钟基因被破坏,我假设这有助于感染肝脏中T细胞反应不良。重要的是,我们最近的数据表明,通过药物操纵昼夜节律途径可以增强CHB患者HBV特异性T细胞的功能。因此,通过研究昼夜节律系统如何调节受感染肝脏中的T细胞免疫以及一天中的时间如何影响HBV疫苗效力,我们将确定T细胞恢复的新治疗机会并提高HBV治疗性疫苗的效力。在更广泛的背景下,组织和局部免疫之间的时钟通信的知识将适用于许多其他病原体。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Supercritical antisolvent-fluidized bed for the preparation of dry powder inhaler for pulmonary delivery of nanomedicine.
  • DOI:
    10.1016/j.ijpharm.2023.123580
  • 发表时间:
    2023-11
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Zhimin Ma;Xuejuan Zhang;Lu Ping;Zicheng Zhong;Xiubing Zhang;Xiaodong Zhuang;Guanlin Wang;Qiupin Guo;Shaofeng Zhan;Zhenwen Qiu;Ziyu Zhao;Qingguo Li;Dandong Luo
  • 通讯作者:
    Zhimin Ma;Xuejuan Zhang;Lu Ping;Zicheng Zhong;Xiubing Zhang;Xiaodong Zhuang;Guanlin Wang;Qiupin Guo;Shaofeng Zhan;Zhenwen Qiu;Ziyu Zhao;Qingguo Li;Dandong Luo
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression.
  • DOI:
    10.1016/j.isci.2023.108763
  • 发表时间:
    2024-01-19
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Zhuang, Xiaodong;Gallo, Giulia;Sharma, Parul;Ha, Jiyeon;Magri, Andrea;Borrmann, Helene;Harris, James M.;Tsukuda, Senko;Bentley, Eleanor;Kirby, Adam;de Neck, Simon;Yang, Hongbing;Balfe, Peter;Wing, Peter A. C.;Matthews, David;Harris, Adrian L.;Kipar, Anja;Stewart, James P.;Bailey, Dalan;McKeating, Jane A.
  • 通讯作者:
    McKeating, Jane A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alan Xiaodong Zhuang其他文献

Posaconazole nanocrystals dry powder inhalers for the local treatment of invasive pulmonary aspergillosis
泊沙康唑纳米混悬型干粉吸入剂用于侵袭性肺曲霉病的局部治疗
  • DOI:
    10.1016/j.ijpharm.2024.124938
  • 发表时间:
    2025-01-05
  • 期刊:
  • 影响因子:
    5.200
  • 作者:
    Xuchun Li;Qing Wang;Jiewen Huang;Xiao Yue;Xuejuan Zhang;Xinxin Fan;Zhian Fang;Guanlin Wang;Zhenwen Qiu;Dandong Luo;Qiupin Guo;Alan Xiaodong Zhuang;Shaofeng Zhan;Qingguo Li;Ziyu Zhao
  • 通讯作者:
    Ziyu Zhao

Alan Xiaodong Zhuang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

基于生命节律的数字化口服给药系统及方法的研究
  • 批准号:
    30700160
  • 批准年份:
    2007
  • 资助金额:
    16.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Targeting Circadian Clock Dysfunction in Alzheimer's Disease (TClock4AD)
针对阿尔茨海默氏病的生物钟功能障碍 (TClock4AD)
  • 批准号:
    EP/X030091/1
  • 财政年份:
    2023
  • 资助金额:
    $ 192.58万
  • 项目类别:
    Research Grant
Targeting the endothelial clock to treat perioperative myocardial ischemia
靶向内皮时钟治疗围手术期心肌缺血
  • 批准号:
    10705355
  • 财政年份:
    2022
  • 资助金额:
    $ 192.58万
  • 项目类别:
Pharmacological targeting of circadian clock components to treat glioblastoma
生物钟成分的药理学靶向治疗胶质母细胞瘤
  • 批准号:
    10685969
  • 财政年份:
    2019
  • 资助金额:
    $ 192.58万
  • 项目类别:
Pharmacological targeting of circadian clock components to treat glioblastoma
生物钟成分的药理学靶向治疗胶质母细胞瘤
  • 批准号:
    10289686
  • 财政年份:
    2019
  • 资助金额:
    $ 192.58万
  • 项目类别:
Pharmacological targeting of circadian clock components to treat glioblastoma
生物钟成分的药理学靶向治疗胶质母细胞瘤
  • 批准号:
    10247630
  • 财政年份:
    2019
  • 资助金额:
    $ 192.58万
  • 项目类别:
Pharmacological targeting of circadian clock components to treat glioblastoma
生物钟成分的药理学靶向治疗胶质母细胞瘤
  • 批准号:
    10470347
  • 财政年份:
    2019
  • 资助金额:
    $ 192.58万
  • 项目类别:
Pharmacological targeting of circadian clock components to treat glioblastoma
生物钟成分的药理学靶向治疗胶质母细胞瘤
  • 批准号:
    9897421
  • 财政年份:
    2019
  • 资助金额:
    $ 192.58万
  • 项目类别:
Pharmacological targeting of circadian clock components to treat glioblastoma
生物钟成分的药理学靶向治疗胶质母细胞瘤
  • 批准号:
    10021619
  • 财政年份:
    2019
  • 资助金额:
    $ 192.58万
  • 项目类别:
Targeting circadian clock genes in leukemia treatment
白血病治疗中针对昼夜节律基因
  • 批准号:
    18K08362
  • 财政年份:
    2018
  • 资助金额:
    $ 192.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting circadian clock mechanisms in the intervertebral disc towards therapies for low back pain
针对椎间盘中的生物钟机制来治疗腰痛
  • 批准号:
    MR/P010709/1
  • 财政年份:
    2017
  • 资助金额:
    $ 192.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了